欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号CZ/H/0615/001
药品名称Imatinib Krka d.d. 100 mg
活性成分
    • imatinib mesilate 119.5 mg
    • imatinib 100.0 mg
剂型Film-coated tablet
上市许可持有人Krka d.d., Novo mesto Šmarješka cesta 6 8501 Novo mesto Slovenia
参考成员国 - 产品名称Czechia (CZ)
IMATINIB KRKA D.D.
互认成员国 - 产品名称
    • Iceland (IS)
    • Greece (GR)
    • Norway (NO)
    • Cyprus (CY)
      ImatinibTAD 100 mg επικαλυμμένα με λεπτό υμένιο δισκία
    • Malta (MT)
      Imatinib TAD 100 mg film-coated tablets
    • Belgium (BE)
      Imatinib Krka 100 mg filmomhulde tabletten
    • United Kingdom (Northern Ireland) (XI)
    • Ireland (IE)
    • Austria (AT)
      Imatinib Krka d.d. 100 mg Filmtabletten
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Sweden (SE)
    • Finland (FI)
    • Denmark (DK)
    • Netherlands (NL)
许可日期2015/12/01
最近更新日期2023/07/24
药物ATC编码
    • L01XE01 imatinib
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase